Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects

Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects

Lung cancer, the second most commonly diagnosed cancer, is the major cause of fatalities worldwide for both men and women, with an estimated 2.2 million new incidences and 1.8 million deaths, according to GLOBOCAN 2020. Although various risk factors for lung cancer pathogenesis have been reported, c...

Full description

Bibliographic Details
Main Authors: Shailendra Kumar Gangwar, Aviral Kumar, Kenneth Chun-Hong Yap, Sandra Jose, Dey Parama, Gautam Sethi, Alan Prem Kumar, Ajaikumar B. Kunnumakkara
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Pharmaceuticals
Subjects:
lung cancer
nuclear receptors
agonists/antagonists
biomarker
cell growth
Online Access:https://www.mdpi.com/1424-8247/15/5/624

Internet

https://www.mdpi.com/1424-8247/15/5/624

Similar Items